Icon Plc is a leading global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in offering a comprehensive range of services that encompass a wide array of phases in the drug development process, from early-stage research and clinical trials to regulatory submissions and post-market support. With a focus on advancing healthcare innovations, Icon collaborates closely with its clients to optimize their product development strategies, improve operational efficiency, and accelerate the path to market for new therapeutic products. Their expertise encompasses various therapeutic areas, providing tailored solutions that address the specific needs of each client. Read More
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 11, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired ICON plc (“ICON” or the “Company”) (NASDAQ: ICLR) ordinary shares between July 27, 2023 and January 13, 2025, inclusive (the “Class Period”).
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in securities class action lawsuits against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023 and January 13, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Eastern District of New York.
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In ICON To Contact Him Directly To Discuss Their Options
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as a Non-Executive Director (NED) based in the United States, effective 7 April 20251.
NEW ORLEANS, April 03, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 11, 2025 to file lead plaintiff applications in securities class action lawsuits against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023 and January 13, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Eastern District of New York.
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024. ICON is a clinical research organization.
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ICON To Contact Him Directly To Discuss Their Options
NEW YORK and NEW ORLEANS, April 01, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Edison International (NYSE:EIX), Elastic N.V. (NYSE:ESTC), Monolithic Power Systems, Inc. (NASDAQ: MPWR), and ICON Public Limited Company (NASDAQ: ICLR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the first quarter 2025 after the market closes on Wednesday, April 30, 2025. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, May 1, 2025 at 8:00am ET.
NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
NEW ORLEANS, March 27, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024. ICON is a clinical research organization (CRO).
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
NEW YORK and NEW ORLEANS, March 25, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company’s shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Edison International (NYSE:EIX), Elastic N.V. (NYSE:ESTC), Intellia Therapeutics, Inc. (NASDAQ:NTLA), and ICON Public Limited Company (NASDAQ: ICLR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ICON Public Limited Company (“ICON”) (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is April 11, 2025.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In ICON To Contact Him Directly To Discuss Their Options
